J, Y., W, X., Y, Z., H, W., X, H., & J, G. (2018). Checkpoint molecule PD-1-assisted CD8+ T lymphocyte count in tumor microenvironment predicts overall survival of patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors. Dove Medical Press.

J, Yao, Xi W, Zhu Y, Wang H, Hu X, and Guo J. Checkpoint Molecule PD-1-assisted CD8+ T Lymphocyte Count in Tumor Microenvironment Predicts Overall Survival of Patients With Metastatic Renal Cell Carcinoma Treated With Tyrosine Kinase Inhibitors. Dove Medical Press, 2018.

J, Yao, et al. Checkpoint Molecule PD-1-assisted CD8+ T Lymphocyte Count in Tumor Microenvironment Predicts Overall Survival of Patients With Metastatic Renal Cell Carcinoma Treated With Tyrosine Kinase Inhibitors. Dove Medical Press, 2018.